Worth reading
59In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
2683
¥ million (year-on-year increase in revenue)Wording
Conditional
How definitive the wording is.Contents of this document
Earnings presentationSecond quarter of the fiscal year ending March 202711 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥20,840 million+14.8%
Operating profit¥2,369 million-5.2%
Ordinary income¥2,181 million-11.8%
Net income¥1,786 million +4.8%interim net income attributable to owners of the parent
Operating profit margin10.2% (second quarter alone of FY2027)
Results for the three months of the current quarter
Net Sales
¥11,085 million
Operating profit
¥1,126 million
Operating profit margin
10.2%
Full-year earnings forecast
Net Sales
¥39,100 million
Operating profit
¥4,800 million
Ordinary income
¥4,900 million
Net income
¥3,400 million net income attributable to owners of the parent
Earnings per share
¥278.55
Annual Dividend
¥180
ROE
7 %
Capital expenditures
¥4,600 million
Depreciation and amortization
¥3,150 million
R&D Expenses
¥820 million
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Operating profit
Sales Volumes¥220 million
Price¥-420 million
Other¥-94 million
Other businesses and eliminations¥164 million
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Rising raw material prices, price pass-through, and resilient shipments in the semiconductor and electronic materials divisions. Numerical assumptions: Not disclosed.New initiatives
- Completed development of a highly selective etchant with greater selectivity than existing products; samples are being evaluated by users.
- PR activities and research promotion toward sales of cell culture containers, targeting sales in FY2027
- Expansion of synthesis examples for high-value-added organofluorine compounds
- Development of cathode active material coating for liquid-based and all-solid-state lithium-ion secondary batteries; the liquid-based battery product is under customer evaluation, while commercialization for all-solid-state batteries is planned around 2030
Key KPIsA metric the company considers important as a management benchmark.
High-purity hydrofluoric acid (semiconductors) shipment volume
37,000 t
Average import trade price of hydrofluoric acid from China
405 Yen/kg
Overseas sales ratio for the High-Purity Chemicals Business
58.1 %
Unit price and quantity metricsThese figures show sales broken down by price and volume.
Semiconductor shipment volume
37,000 t
Average import trade price of hydrofluoric acid from China
405 Yen/kg
Segment results
High-purity chemicals
Net Sales
¥18,092 million+14.5%
Operating profit
¥1,789 million-14.1%
Transportation
Net Sales
¥2,692 million+16.2%
Operating profit
¥576 million+39.0%
Other
Net Sales
¥55 million+28.7%
Operating profit
¥9 million-7.1%
Financial targets
ROE
Actual results for the fiscal year ending March 20266.6 %
Forecast for the fiscal year ending March 20277 %
Capital expenditures
¥1,205 million cumulative second quarter of the fiscal year ending March 2027
Annual Dividend
Annual
¥180 per share
Interim
¥90 per share
End of period
¥90 per share
Payout ratio
Total payout ratio: target of at least 100% cumulatively over the 3-year period from the fiscal year ended March 2026 through the fiscal year ending March 2028Acquisition of treasury shares
¥1.6 billion
Number of Shares300,000 shares
Period7 August 2026–14 October 2026
| Item | Details |
|---|---|
| Document type | Earnings presentation |
| Fiscal Period Covered | Second quarter of the fiscal year ending March 2027 |
| Net Sales | ¥20,840 million (YoY +14.8%) |
| Operating profit | ¥2,369 million (YoY -5.2%) |
| Ordinary income | ¥2,181 million (YoY -11.8%) |
| Net income | ¥1,786 million (interim net income attributable to owners of the parent) (YoY +4.8%) |
| Operating profit margin | 10.2% (second quarter alone of FY2027) |
| Results for the three months of the current quarter | Net Sales ¥11,085 million / Operating profit ¥1,126 million / Operating profit margin 10.2% |
| Full-year earnings forecast | Net Sales ¥39,100 million / Operating profit ¥4,800 million / Ordinary income ¥4,900 million / Net income ¥3,400 million (net income attributable to owners of the parent) / Earnings per share ¥278.55 / Annual Dividend ¥180 / ROE 7 % / Capital expenditures ¥4,600 million / Depreciation and amortization ¥3,150 million / R&D Expenses ¥820 million |
| Segment results | High-purity chemicals Net Sales ¥18,092 million (YoY +14.5%) / Operating profit ¥1,789 million (YoY -14.1%) / Transportation Net Sales ¥2,692 million (YoY +16.2%) / Operating profit ¥576 million (YoY +39.0%) / Other Net Sales ¥55 million (YoY +28.7%) / Operating profit ¥9 million (YoY -7.1%) |
| Breakdown of Factors Affecting the Change | Operating profit Sales Volumes ¥220 million / Price ¥-420 million / Other ¥-94 million / Other businesses and eliminations ¥164 million |
| Key KPIs | High-purity hydrofluoric acid (semiconductors) shipment volume 37,000 t / Average import trade price of hydrofluoric acid from China 405 Yen/kg / Overseas sales ratio for the High-Purity Chemicals Business 58.1 % |
| Unit price and quantity metrics | Semiconductor shipment volume 37,000 t / Average import trade price of hydrofluoric acid from China 405 Yen/kg |
| Assumptions Underlying the Business Outlook | Rising raw material prices, price pass-through, and resilient shipments in the semiconductor and electronic materials divisions. Numerical assumptions: Not disclosed. |
| Financial targets | ROE Actual results for the fiscal year ending March 2026 6.6 % / Forecast for the fiscal year ending March 2027 7 % |
| Annual Dividend | Annual ¥180 per share / Interim ¥90 per share / End of period ¥90 per share |
| Payout ratio | Total payout ratio: target of at least 100% cumulatively over the 3-year period from the fiscal year ended March 2026 through the fiscal year ending March 2028 |
| Acquisition of treasury shares | Number of Shares 300,000 shares / Amount ¥1.6 billion / Period 7 August 2026–14 October 2026 |
| Capital expenditures | ¥1,205 million (cumulative second quarter of the fiscal year ending March 2027) |
| New initiatives | Completed development of a highly selective etchant with greater selectivity than existing products; samples are being evaluated by users., PR activities and research promotion toward sales of cell culture containers, targeting sales in FY2027, Expansion of synthesis examples for high-value-added organofluorine compounds, Development of cathode active material coating for liquid-based and all-solid-state lithium-ion secondary batteries; the liquid-based battery product is under customer evaluation, while commercialization for all-solid-state batteries is planned around 2030 |
Items this document does not state (11)
Gross Profit MarginSelling, general and administrative expensesProgress against full-year forecastSelf-assessment against the planNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue increased due to price pass-through in areas including the semiconductor division, higher shipment volumes in the electronic materials division, increased sales in the purchased products division, and higher freight-handling volumes. Operating profit declined despite the benefits of price pass-through and higher earnings in the transportation business, owing to higher raw material prices, including those of anhydrous hydrofluoric acid, and increased expenses. Net income attributable to owners of the parent increased due to the recognition of a gain on changes in equity interests associated with the capital increase by ステラファーマ.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.